Trademark: 98107716
Word
NAVKYOS
Status
Pending
Status Code
686
Status Date
Tuesday, April 23, 2024
Serial Number
98107716
Mark Type
4
Filing Date
Friday, July 28, 2023
Published for Opposition
Tuesday, April 23, 2024

Trademark Owner History
Vertex Pharmaceuticals Incorporated - Owner At Publication

Classifications
5 Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease

Trademark Events
Aug 1, 2023
New Application Entered
Aug 28, 2023
New Application Office Supplied Data Entered
Mar 19, 2024
Assigned To Examiner
Mar 19, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24